| Title: |
Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia |
| Authors: |
Jenkins, Chelsea; Luty, Samuel B.; Maxson, Julia E.; Eide, Christopher A.; Abel, Melissa L.; Togiai, Corinne; Nemecek, Eneida R.; Bottomly, Daniel; McWeeney, Shannon K.; Wilmot, Beth; Loriaux, Marc; Chang, Bill H.; Tyner, Jeffrey W. |
| Contributors: |
National Cancer Institute; V Foundation for Cancer Research; American Society of Hematology; Gabrielle’s Angel Foundation for Cancer Research; Leukemia and Lymphoma Society; National Center for Advancing Translational Sciences |
| Source: |
Science Signaling ; volume 11, issue 539 ; ISSN 1945-0877 1937-9145 |
| Publisher Information: |
American Association for the Advancement of Science (AAAS) |
| Publication Year: |
2018 |
| Description: |
Dasatinib or TNK2-specific inhibitors may treat PTPN11-mutant leukemia. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1126/scisignal.aao5617 |
| Availability: |
https://doi.org/10.1126/scisignal.aao5617; https://syndication.highwire.org/content/doi/10.1126/scisignal.aao5617; https://www.science.org/doi/pdf/10.1126/scisignal.aao5617 |
| Accession Number: |
edsbas.9D96055D |
| Database: |
BASE |